TEECAD System provided safe and effective probe placement   March 27, 2025 – Minneapolis, MN - Visura Technologies , Inc.,   a priv...

Initial results support the use of TEECAD to eliminate blind transesophageal echocardiography (TEE) intubations and improve physician...

The clear need for real-time, direct visualization to guide transesophageal echocardiogram (TEE) intubations continues to drive adoption...

Cardiologist and President of Metropolitan Heart and Vascular Institute in Minneapolis joins the Visura team to support the advancement...

Company Committed to TEECAD for Use with Smaller Transesophageal Echocardiography (TEE) Probes MINNEAPOLIS, June 12, 2024 -- Visura...

Commercial and Business Development team to accelerate the adoption of TEECAD at heart centers across the US MINNEAPOLIS, March 25,...

Visura Technologies and YKK Corporation of America announce a new joint venture to better serve the Minneapolis ecosystem of emerging...

TEECAD System now compatible for use with GE HealthCare and Siemens Healthineers TEE adult probes. MINNEAPOLIS, MN (June 22, 2023)...

First ever clinical data on an innovation specifically designed to advance the TEE procedure will be presented at global echocardiography...

Funding will support company’s rapid, full commercialization of its TEECAD® System MINNEAPOLIS (January 18, 2022) —Visura Technologies,...

TEECAD Innovation to be Showcased at Upcoming Mayo Clinic Continuing Education and American Society of Echocardiography (ASE) Meetings...

In a recent article in MassDevice’s Medical Design and Outsourcing publication, Visura was recognized as one of ten up-and-coming medical...

TEECAD Innovation Station offers attendees time with experts and technology MINNEAPOLIS, MN (June 7, 2022) —Visura Technologies, Inc., a...

Visura Technologies will be attending the 33rd Annual American Society of Echocardiography (ASE) Scientific Sessions at the Seattle...

Horton joins the rapidly growing cardiology company to lead U.S. commercialization efforts